SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-008958
Filing Date
2020-08-03
Accepted
2020-08-03 09:53:24
Documents
49
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rytm-20200630x10q.htm   iXBRL 10-Q 1562383
2 EX-10.1 rytm-20200630xex10d1.htm EX-10.1 31597
3 EX-31.1 rytm-20200630xex31d1.htm EX-31.1 12965
4 EX-31.2 rytm-20200630xex31d2.htm EX-31.2 14736
5 EX-32.1 rytm-20200630xex32d1.htm EX-32.1 7194
6 EX-32.2 rytm-20200630xex32d2.htm EX-32.2 7900
  Complete submission text file 0001558370-20-008958.txt   4472521

Data Files

Seq Description Document Type Size
7 EX-101.SCH rytm-20200630.xsd EX-101.SCH 23461
8 EX-101.CAL rytm-20200630_cal.xml EX-101.CAL 36234
9 EX-101.DEF rytm-20200630_def.xml EX-101.DEF 73341
10 EX-101.LAB rytm-20200630_lab.xml EX-101.LAB 269961
11 EX-101.PRE rytm-20200630_pre.xml EX-101.PRE 186408
12 EXTRACTED XBRL INSTANCE DOCUMENT rytm-20200630x10q_htm.xml XML 582011
Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Filer) CIK: 0001649904 (see all company filings)

IRS No.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38223 | Film No.: 201068174
SIC: 2834 Pharmaceutical Preparations